Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|December 6, 2006
The autocrine TNFalpha signalling loop in keratinocytes requires atypical PKC species and NF-kappaB activation but is independent of cholesterol-enriched membrane microdomainsSteen Lisby, Annesofie Faurschou, Robert Gniadecki
Experimental Dermatology|April 28, 2005
UV-induced DNA damage in human keratinocytes: quantitation and correlation with long-term survivalSteen Lisby, Robert Gniadecki, Hans Christian Wulf
Contact Dermatitis|October 9, 2003
Release of nickel ions from stainless steel alloys used in dental braces and their patch test reactivity in nickel-sensitive individualsChristian Stab Jensen, Steen Lisby, Ole Baadsgaard, et al.
Contact Dermatitis|December 18, 2003
Experimental systemic contact dermatitis from nickel: a dose-response studyChristian S Jensen, Torkil Menné, Steen Lisby, et al.
Contact Dermatitis|April 3, 2004
Characterization of lymphocyte subpopulations and cytokine profiles in peripheral blood of nickel-sensitive individuals with systemic contact dermatitis after oral nickel exposureChristian Stab Jensen, Steen Lisby, Jørgen K Larsen, et al.
Blood|August 23, 2011
Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international studyWilliam G Wierda, Swaminathan Padmanabhan, Geoffrey W Chan, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2014
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neckVassiliki Saloura, Ezra E W Cohen, Lisa Licitra, et al.
Neurology|January 24, 2014
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 studyPer S Sorensen, Steen Lisby, Richard Grove, et al.
The Lancet. Oncology|March 8, 2011
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trialJean-Pascal Machiels, Somasundaram Subramanian, Agnes Ruzsa, et al.
British Journal of Haematology|March 14, 2012
Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphomaMyron S Czuczman, Georg Hess, Ole V Gadeberg, et al.
Pageof 3